- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 203
BMW picks competition winner
BMW will double the prize money awarded to winners of New York City's BigApps 2.0 event
Mar 27, 2011SVB finds the Color is green
Color raises $41m in green dollar bills from venture capital firms Bain Capital Ventures and Sequoia Capital and debt and equity provider Silicon Valley Bank.
Mar 25, 2011Glam Media adds BBS Media
Mark Boxer and Brian Fields, BBS Media's co-founders, will serve as vice-presidents of Glam Media Canada and in charge of publisher and brand-advertising sales.
Mar 20, 2011Veolia accelerates innovation partnering
Veolia Innovation Accelerator has partnered five companies, including Envolure, a France-based environmental analysis maker, software company Cosmo, Canada-based Ostara Nutrient Recovery Technologies, GreenRoad, a US fuel-saving start-up, and Advanced Cyclone Systems, a Portugual-based company to filter industrial pollutants.
Mar 20, 2011Comcast joins SeedStart Media 2011
New York City-based SeedStart Media 2011 is a summer programme for start-up companies in digital content, e-commerce, advertising infrastructure and mobile technology.
Mar 6, 2011Saint-Gobain picks three winners
The winners of Saint-Gobain's third global innovation competition will also work with its Nova External Venturing team.
Mar 1, 2011Citrix accelerates first venture
Citrix Startup Accelerator has invested an undisclosed sum in Primadesk, a service to help users search, manage and backup their personal cloud data.
Mar 1, 2011Laing builds on Novacem deal
A series A round is expected by mid-2011, Novacem said, after UK-based construction company Laing O'Rourke joins a $3m seed round.
Feb 23, 2011Novo seeds Orphazyme Aps
Joining Henrijette Richter, investment director at Novo, in the seed round is venture capital firm Sunstone Capital.
Feb 19, 2011Cleveland Clinic backs SironRX
SironRX spun out from Juventas Therapeutics and licenses products from its parent and Cleveland Clinic and will use the $500,000 seed money to initiate a phase II clinical study of its lead product.
Feb 11, 2011About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


